KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Liabilities and Shareholders Equity (2016 - 2026)

Supernus Pharmaceuticals has reported Liabilities and Shareholders Equity over the past 15 years, most recently at $1.5 billion for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity rose 6.18% to $1.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.6 billion through Dec 2025, up 5.09% year-over-year, with the annual reading at $1.5 billion for FY2025, 6.18% up from the prior year.
  • Liabilities and Shareholders Equity was $1.5 billion for Q4 2025 at Supernus Pharmaceuticals, up from $1.4 billion in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $1.8 billion in Q1 2023 and troughed at $1.3 billion in Q4 2023.
  • The 5-year median for Liabilities and Shareholders Equity is $1.4 billion (2025), against an average of $1.5 billion.
  • Year-over-year, Liabilities and Shareholders Equity grew 26.69% in 2021 and then fell 27.22% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $1.7 billion in 2021, then increased by 0.79% to $1.7 billion in 2022, then fell by 24.95% to $1.3 billion in 2023, then increased by 7.08% to $1.4 billion in 2024, then rose by 6.18% to $1.5 billion in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Liabilities and Shareholders Equity are $1.5 billion (Q4 2025), $1.4 billion (Q3 2025), and $1.4 billion (Q2 2025).